S
Sascha Seidel
Researcher at University of Giessen
Publications - 11
Citations - 1433
Sascha Seidel is an academic researcher from University of Giessen. The author has contributed to research in topics: Glioma & Stem cell. The author has an hindex of 9, co-authored 10 publications receiving 1221 citations. Previous affiliations of Sascha Seidel include Goethe University Frankfurt.
Papers
More filters
Journal ArticleDOI
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Suphansa Sawamiphak,Sascha Seidel,Clara L. Essmann,George A. Wilkinson,Mara E. Pitulescu,Till Acker,Amparo Acker-Palmer +6 more
TL;DR: It is suggested that blocking ephrin-B2 reverse signalling may be an attractive alternative or combinatorial anti-angiogenic therapy strategy to disrupt VEGFR2 function in tumour angiogenesis.
Journal ArticleDOI
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
Sascha Seidel,Boyan K. Garvalov,Valtteri Wirta,Louise von Stechow,Anne Schänzer,Konstantinos Meletis,Marietta Wolter,Daniel Sommerlad,Anne-Theres Henze,Monica Nistér,Guido Reifenberger,Joakim Lundeberg,Jonas Frisén,Jonas Frisén,Till Acker,Till Acker,Till Acker +16 more
TL;DR: It is proposed that tumour stem cells are maintained within a hypoxic niche, providing a functional link between the well-established role of hypoxia in stem cell and tumour biology.
Journal ArticleDOI
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body
Chenchen Pan,Oliver Schoppe,Arnaldo Parra-Damas,Ruiyao Cai,Mihail Ivilinov Todorov,Gabor Gondi,Bettina von Neubeck,Nuray Böğürcü-Seidel,Sascha Seidel,Katia Sleiman,Katia Sleiman,Christian Veltkamp,Christian Veltkamp,Benjamin Förstera,Hongcheng Mai,Zhouyi Rong,Omelyan Trompak,Alireza Ghasemigharagoz,Madita Alice Reimer,Ángel M. Cuesta,Javier Coronel,Irmela Jeremias,Dieter Saur,Dieter Saur,Amparo Acker-Palmer,Till Acker,Boyan K. Garvalov,Boyan K. Garvalov,Bjoern H. Menze,Reinhard Zeidler,Ali Ertürk +30 more
TL;DR: An integrated pipeline for automated quantification of cancer metastases and therapeutic antibody targeting, named DeepMACT, which enhanced the fluorescent signal of cancer cells more than 100-fold by applying the vDISCO method and can considerably improve the discovery of effective antibody-based therapeutics at the pre-clinical stage.
Journal ArticleDOI
Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression
Marco Reis,Cathrin J. Czupalla,Nicole Ziegler,Kavi Devraj,Jenny Zinke,Sascha Seidel,Rosario Heck,Sonja Thom,Jadranka Macas,Ernesto Bockamp,Marcus Fruttiger,Makoto Mark Taketo,Stefanie Dimmeler,Karl H. Plate,Stefan Liebner +14 more
TL;DR: Wnt modulates glioma vascularization by regulating PDGF-B expression and prevents programmed cell death in gliomas by reprograming the “wnt-like” signaling pathway.
Journal ArticleDOI
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Anne-Theres Henze,Boyan K. Garvalov,Sascha Seidel,Ángel M. Cuesta,Mathias Ritter,Mathias Ritter,Alina Filatova,Franziska Foss,Franziska Foss,Higinio Dopeso,Clara L. Essmann,Patrick H. Maxwell,Guido Reifenberger,Peter Carmeliet,Amparo Acker-Palmer,Amparo Acker-Palmer,Till Acker +16 more
TL;DR: The findings reveal that PHD3 inactivation provides an alternative route of EGFR activation through which tumour cells sustain proliferative signalling even under conditions of limited oxygen availability.